Questions about SSRI antidepressant drug regulation.
Hay
Alastair
A
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D002170:Canada; D003866:Depressive Disorder / Q000188:drug therapy*; D030881:Disclosure; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013405:Suicide; D006113:United Kingdom; D014481:United States
D018687:Antidepressive Agents, Second-Generation; D017367:Selective Serotonin Reuptake Inhibitors